The spread of Dengue Hemorrhagic Fever (DBD) in the capital is difficult to treat properly. Various studies have done to create the right formula to prevent viral infection caused by the bite of Aedes Aegypty mosquito.

Do not know when, but we very happy if it can be marketed next year

A pharmaceutical company in France managed in providing a vaccine that can cure dengue quickly. With the vaccine, not only speed up the healing process of dengue but also reduce the cost of treatment. However, it is not known when the vaccine can be distributed, especially to the capital.

"Do not know when, but we very happy if it can be marketed next year. Later, the Ministry of Health will publish if it has been circulated," said Dien Emmawati, Head of Jakarta Health Department, Saturday (25/10).

According to Dien, none of the area in Indonesia is free of endemic dengue disease. With the vaccine, people with high risk of contracting dengue can be protected. "So far there is no free area endemic. Every year the averaged have 8 thousand cases," she said.

Although the exact price is still unknown, the vaccine is planned to circulate in 2015, but the estimated price treatment of dengue patients would be cheaper than today.

"If hospitalizations could spend between Rp 5-6 million, while if the price of the vaccine may be only Rp 150-200 thousand. If the outside, it probably will be free for those who can not afford, while the rich people should buy," she explained.

In 2013, in Jakarta 10,156 dengue cases were recorded with the number of deaths reached 20 people. While in 2014, until the beginning of June already reached 5,891 cases with 6 deaths.